Literature DB >> 29158217

Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity.

Marion Escudier1,2,3, Jennifer Cautela1,2,3,4, Nausicaa Malissen5, Yann Ancedy6, Morgane Orabona1,2,3, Johan Pinto1,2,3, Sandrine Monestier5, Jean-Jacques Grob5, Ugo Scemama7, Alexis Jacquier7, Nathalie Lalevee8, Jeremie Barraud1,2, Michael Peyrol1,2, Marc Laine1,2, Laurent Bonello1,2,9, Franck Paganelli1,2,9, Ariel Cohen6, Fabrice Barlesi1,4,10, Stephane Ederhy6, Franck Thuny11,3,4.   

Abstract

Entities:  

Keywords:  cardiotoxicity; immunotherapy; neoplasms

Mesh：

Substances：

Year:  2017        PMID： 29158217     DOI： 10.1161/CIRCULATIONAHA.117.030571

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  111 in total

Review 1.  Cardiotoxicity of Immune Checkpoint Inhibitors.

Authors:  Lili Zhang; Maeve Jones-O'Connor; Magid Awadalla; Daniel A Zlotoff; Paaladinesh Thavendiranathan; John D Groarke; Alexandra-Chloe Villani; Alexander R Lyon; Tomas G Neilan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-06-08

Review 2.  [Novel cancer treatment and the cardiovascular risk : What should cardiologists know?]

Authors:  Matthias Totzeck; Tienush Rassaf
Journal:  Herz       Date:  2020-04       Impact factor: 1.443

Review 3.  Biomarker Discovery in Cardio-Oncology.

Authors:  Anita Vohra; Aarti Asnani
Journal:  Curr Cardiol Rep       Date:  2018-05-25       Impact factor: 2.931

4.  Immune Checkpoint Inhibitor-Related Cardiotoxicity.

Authors:  Barry Trachtenberg; Fahd Hussain; Akash Mukherjee; Raquel Araujo-Gutierrez; Sai Ravi Kiran Pingali
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

Review 5.  Cardiovascular toxicities associated with immune checkpoint inhibitors.

Authors:  Jiun-Ruey Hu; Roberta Florido; Evan J Lipson; Jarushka Naidoo; Reza Ardehali; Carlo G Tocchetti; Alexander R Lyon; Robert F Padera; Douglas B Johnson; Javid Moslehi
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

Review 6.  Toxicity of tumor immune checkpoint inhibitors-more attention should be paid.

Authors:  Yu Liu; Hao Wang; Juan Deng; Chenglong Sun; Yayi He; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2019-12

7.  [Curing cancer and protecting the heart : Challenges in cardio-oncology in the era of modern tumor treatment].

Authors:  C Hohmann; S Baldus; R Pfister
Journal:  Herz       Date:  2019-04       Impact factor: 1.443

8.  Immune Checkpoint Inhibitor-Associated Pericarditis.

Authors:  Mehmet Altan; Maria I Toki; Scott N Gettinger; Daniel E Carvajal-Hausdorf; Jon Zugazagoitia; John H Sinard; Roy S Herbst; David L Rimm
Journal:  J Thorac Oncol       Date:  2019-03-07       Impact factor: 15.609

Review 9.  Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer.

Authors:  Iosune Baraibar; Ignacio Melero; Mariano Ponz-Sarvise; Eduardo Castanon
Journal:  Drug Saf       Date:  2019-02       Impact factor: 5.606

Review 10.  Cardio-toxicity of checkpoint inhibitors.

Authors:  Oliver J Müller; Martina E Spehlmann; Norbert Frey
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.